Canton Strategic Holdings (CNTN) Assets Average (2022 - 2026)
Canton Strategic Holdings posted quarterly Assets Average of $551.9 million for Q1 2026, up 20405.63% year-on-year from N/an in Q1 2025, and up 109.51% on a QoQ basis from $263.4 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 5 years of Assets Average data on file, last reported at $551.9 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 20405.63% year-over-year to $551.9 million; the trailing twelve-month figure through Mar 2026 stood at $551.9 million (up 20405.63% YoY), and the FY2025 full-year result was $261.4 million, up 3464.68% from the prior year.
- Assets Average for Q1 2026 stood at $551.9 million, up from $263.4 million in the prior quarter.
- Across five years, Assets Average topped out at $551.9 million in Q1 2026 and bottomed at $2.1 million in Q2 2025.
- The 5-year median for Assets Average is $6.8 million (2024), against an average of $53.5 million.
- The widest annual swing landed in 2025, when Assets Average slumped 75.55%; it then surged 20405.63% in 2026.
- A 5-year view of Assets Average shows it stood at $7.4 million in 2022, then fell by 4.04% to $7.1 million in 2023, then plunged by 36.42% to $4.5 million in 2024, then jumped by 5771.54% to $263.4 million in 2025, then soared by 109.51% to $551.9 million in 2026.
- The last three Assets Average figures came in at $551.9 million (Q1 2026), $263.4 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | 551.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 551.90 Mn |
| Dec 31, 2025 | 263.42 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Dec 31, 2024 | 4.49 Mn |
| Sep 30, 2024 | 6.75 Mn |
| Jun 30, 2024 | 8.57 Mn |
| Mar 31, 2024 | 9.92 Mn |
| Dec 31, 2023 | 7.06 Mn |
| Sep 30, 2023 | 3.88 Mn |
| Jun 30, 2023 | 4.66 Mn |
| Mar 31, 2023 | 5.71 Mn |
| Dec 31, 2022 | 7.35 Mn |
| Sep 30, 2022 | 9.13 Mn |
| Jun 30, 2022 | 11.17 Mn |
| Mar 31, 2022 | 6.36 Mn |